EFSA gut/immune health meeting

Danone tells EFSA: Health claims “learning experience” is too costly

This content item was originally published on www.nutraingredients.com, a William Reed online publication.

By Shane Starling

- Last updated on GMT

Related tags: Efsa, Nutrition

Danone says there is not enough claims clarity to make a submission for Actimel and other products
Danone says there is not enough claims clarity to make a submission for Actimel and other products
The European Food Safety Authority (EFSA) has repeatedly emphasised that the 2006 EU nutrition and health claims regulation is a learning experience for everyone involved – from its health claims assessment panel to industry stakeholders, to the member states and the European Commission.

That may be so, but it is a highly expensive learning process, with the greatest burden of cost being borne by industry players like Danone, the company’s vice president of research and development in its dairy division, Frederic René, said after EFSA’s gut/immune function meeting in Amsterdam last week.

With Danone having twice submitted and then withdrawn dossiers for its probiotic yoghurts Actimel and Activia, citing a lack of clarity from EFSA at the time of both withdrawals, René said EFSA needed to be more communicative with applicants.

He said it was not acceptable that EFSA undertook its learning process by analysing dossiers and publishing opinions on them.

“It’s a trial and error process and I don’t think it is the right way to make a learning process.”

Like several others at the meeting, he proposed pre-screening of dossiers by EFSA’s Dietetic Products, Nutrition and Allergies (NDA) panel, a proposal NDA chief, Professor Albert Flynn, said was unlikely due to a lack of resources.

Lack of depth and precision

René said he was disappointed by the lack of specific guidance forthcoming at the meeting, save for some advice on clinical outcomes.

“In fact there is nothing really new,” ​he said. “We need to be more precise and maybe go in depth as proposed by many of the people attending the meeting.”

He said the situation remained unclear as to when health claim submissions for Activia and Actimel may be formally submitted to the process for a third time.

Related news

Show more

Related products

show more

Benefit from our plant-based dairy expertise.

Benefit from our plant-based dairy expertise.

ADM | 01-Nov-2022 | Case Study

Are you looking to elevate your work in plant-based dairy? ADM is ready to help with a full ingredient pantry and advanced formulation expertise to meet...

Discover the secret to exceptional non-dairy m*lks

Discover the secret to exceptional non-dairy m*lks

Amano Enzyme Inc. | 21-Oct-2022 | Infographic

We’ve cracked the great non-dairy m*lk puzzle! Put an end to your plant-based m*lk formulation woes with our enzymes – the missing puzzle piece you’ve...

Dairy Ingredient Solutions For Every Application

Dairy Ingredient Solutions For Every Application

Corbion | 04-Oct-2022 | Product Brochure

Better texture. Better stability. Better consistency. These are just some of the benefits Corbion® SMART solutions deliver to help you exceed your customers’...

Related suppliers

Follow us

Products

View more

Webinars